Beqalzi

News

BeOne gets the nod for BCL2 inhibitor Beqalzi in mantle cell lymphoma, while Taiho's Inqovi has acute myeloid leukaemia added to its label.

News

Roche has won US FDA clearance for a blood test that could move Alzheimer’s biomarker testing further into primary care.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.